LLY

ASTS Biotechnology DECK DRUG GME HIVE LLY MBLY Uncategorized VTYX

Biggest stock movers Wednesday: GME, VTYX, MBLY, and more

Jan 7, 2026

AMGN Biotechnology LLY Uncategorized

Amgen upgraded to buy at UBS on potential of MariTide, olpasiran

Jan 6, 2026

ARWR Biotechnology LLY Uncategorized

Arrowhead gains as obesity therapy doubles wight loss with Lilly’s Zepbound

Jan 6, 2026

vanda-surges-on-fda-approval-of-lilly-partnered-motion-sickness-therapy

Biotechnology LLY Uncategorized VNDA

Vanda surges on FDA approval of Lilly-partnered motion sickness therapy

Dec 31, 2025

On the Move Comments (4) Grandbrothers/iStock Editorial via Getty Images Vanda Pharmaceuticals (VNDA) added ~21%...

ABVX Biotechnology CGON CNTA JANX LLY MDGL RCUS RVMD SLDB Uncategorized

Here are the most and least likely M&A targets in biotech, according to Truist

Dec 23, 2025

abbvie,-bristol-myers,-merck-among-latest-to-announce-us.-drug-pricing-deals:-reuters

ABBV AZN Biotechnology BMY GILD LLY MRK NVO NVS PFE RHHBY Uncategorized

AbbVie, Bristol Myers, Merck among latest to announce U.S. drug pricing deals: Reuters

Dec 19, 2025

Comments (11) LIgorko/iStock via Getty Images Leading drugmakers, including AbbVie (ABBV), Bristol Myers Squibb (BMY),...

ABBV AMGN AZN Biotechnology BMY GILD GSK JNJ LLY MKGAF MRK NVO NVS PFE REGN SNY Uncategorized

More pharmas expected to sign drug pricing deals with Trump on Friday – report

Dec 17, 2025

ABVX Biotechnology LLY Uncategorized

Eli Lilly acquisition rumors reportedly fuel Abivax rally

Dec 10, 2025

eli-lilly-completes-acquisition-of-adverum-biotechnologies

ADVM Biotechnology LLY Uncategorized

Eli Lilly completes acquisition of Adverum Biotechnologies

Dec 9, 2025

M&A Comments (3) Eli Lilly (LLY) has completed its acquisition of Adverum Biotechnologies (ADVM), and...